GILEAD SCIENCES, INC. |
Market Closed -
Other stock markets
|
Pre-market 03:38:26 am | |||
| 64.92 USD | -0.82% |
|
65.18 | +0.39% |
| 07/05 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
| 02/05 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Trading Ideas